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Microbial pathogens utilize complex secretion systems to deliver proteins into host cells. These effector pro-
teins target and usurp host cell processes to promote infection and cause disease. While secretion systems
are conserved, each pathogen delivers its own unique set of effectors. The identification and characterization
of these effector proteins has been difficult, often limited by the lack of detectable signal sequences and func-
tional redundancy. Model systems including yeast, worms, flies, and fish are being used to circumvent these
issues. This technical review details the versatility and utility of yeast Saccharomyces cerevisiae as a system
to identify and characterize bacterial effectors.The Awesome Power of Yeast Genetics and Genomics
There are many advantages to working with the yeast, S. cerevi-
siae. It is easy to grow in the laboratory, genetically tractable, and
has been used as amodel system for studying eukaryotic cellular
processes for over 50 years. These studies have provided
insights into fundamental eukaryotic processes, including tran-
scription, translation, RNA processing, cell signaling, cytoskele-
tal dynamics, and vesicle trafficking. Presently, over 75% of
yeast ORFs have known or predicted functions, and much of
this information is easily accessible in a variety of databases
on the world wide web (see Table 1 for a listing of the sites).
Many tools and resources are available for designing and ex-
ecuting both genome-wide (discovery-driven) and smaller-scale
(hypothesis-driven) experiments. In addition to comprehensive
yeast DNA (DeRisi et al., 1997) and protein microarrays (Zhu
et al., 2000), several isogenic strain collections are available
where each strain carries a genetically altered version of one of
the 6200 annotated ORFs. These alterations include targeted
gene deletions for use in phenotypic assays (Giaever et al.,
2002), fusions of each ORF to GFP for subcellular localization
studies (Huh et al., 2003), tandem affinity tags for protein expres-
sion and coimmunoprecipitation assays (Ghaemmaghami et al.,
2003), and fusions to the GAL4-binding domain for two-hybrid
assays (Uetz et al., 2000). Strain collections that conditionally
overexpress each of the annotated yeast ORFs also exist
(Gelperin et al., 2005; Sopko et al., 2006).
The utilization of yeast in the study of pathogenic microbes
relies on the observation that bacterial effector proteins often tar-
get eukaryotic cellular processes conserved between yeast and
mammals. Currently, Agrobacterium tumefaciens, a plant patho-
gen, is the only pathogen known to be capable of delivering
proteins directly through the yeast cell wall into the cytoplasm
via its specialized type IV secretion system (Piers et al., 1996).
Thus, rather than studying effector proteins in the context of an
infection, individual effector proteins are expressed de novo in
yeast. For this reason, the yeast system is particularly applicable
for studying proteins thought to act within host cells. In addition,8 Cell Host & Microbe 4, July 17, 2008 ª2008 Elsevier Inc.since this system only requires DNA, it provides a valuable
resource for studying effector proteins from pathogens that are
difficult to grow or genetically manipulate. Expression of effector
proteins can lead to a variety of discernable phenotypes in yeast
(discussed below) that can lead to testable hypotheses regard-
ing their functions and/or their roles in pathogenesis. Once
generated, hypotheses can be pursued in yeast as well as in
physiologic models of disease.
Expression of Bacterial Effector Proteins in Yeast
There is increasing evidence that yeast growth inhibition due to
the expression of bacterial proteins is a sensitive and specific in-
dicator of the activity of effector proteins that perturb conserved
cellular processes. Effector proteins from both plant and animal
pathogens—including Pseudomonas syringae (Munkvold et al.,
2008), Pseudomonas aeruginosa (Rabin and Hauser, 2003;
Sato et al., 2003; Stirling and Evans, 2006), Shigella flexneri
(Alto et al., 2006; Slagowski et al., 2008),Salmonella typhimurium
(Aleman et al., 2005; Lesser and Miller, 2001; Rodriguez-Pachon
et al., 2002), Legionella pneumophila (Campodonico et al., 2005;
Derre and Isberg, 2005), Chlamydia trachomatis (Sisko et al.,
2006), enteropathogenic E. coli (Hardwidge et al., 2005; Rodri-
guez-Escudero et al., 2005), and Yersinia species (Lesser and
Miller, 2001; Nejedlik et al., 2004; Von Pawel-Rammingen
et al., 2000)—have been observed to inhibit growth when ex-
pressed in yeast. In contrast, expression of very few nontranslo-
cated proteins affects yeast growth (Campodonico et al., 2005;
Slagowski et al., 2008).
Since a priori it is not known whether expression of the pro-
teins will be toxic to yeast, it is best to first express an effector
protein under the control of an inducible promotor. This is most
commonly accomplished by use of the GAL1/10 promotor,
a strong promotor whose activity is regulated by the carbon
source in the media. However, this promotor is slightly leaky un-
der repressing conditions, and expression of extremely toxic ef-
fector proteins can be difficult in this system (Slagowski et al.,
2008; Stirling and Evans, 2006). Alternatively, effector proteins
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Saccharomyces Genome Database (SGD) http://www.yeastgenome.org SGD is an organized collection of genetic and
molecular biological information about
annotated yeast ORFs
The Yeast Proteome Database (YPD) https://www.proteome.com/proteome This is a commercial comprehensive database
of information regarding annotated yeast ORFs
Comprehensive Yeast Genome Database
(CYGD-MIPS)
http://mips.gsf.de/genre/proj/yeast/index.jsp CYGD presents information on the molecular
structure and functional network
of S. cerevisiae
Biomolecular Interaction Network Database
(BIND)
http://bind.ca BIND is a database designed to store full
descriptions of interactions, molecular
complexes and pathways
Yeast GFP Fusion Localization Database http://yeastgfp.ucsf.edu This database is a repository for localization
of GFP fusion proteins in yeast
Yeast Protein Localization Database (YPL) http://ypl.uni-graz.at/pages/home.html This database is a repository for global
analyses of localization studies in yeast
Virtual Library—Yeast http://www.yeastgenome.org/VL-yeast.html Source for general information regarding yeast
as an experimental model
Open Biosystems http://www.openbiosystems.com/
GeneExpression/Yeast
Commercial source for yeast deletion
and overexpressor strain collections
Euroscarf: European Saccharomyces
Cerevisiae Archive for Functional Analyses
http://web.uni-frankfurt.de/fb15/mikro/
euroscarf/index.html
Source of yeast deletion stains as well as other
useful yeast strains and expression plasmids
Invitrogen http://clones.invitrogen.com/cloneinfo.
php?clone=yeastgfp
Commercial source for both yeast deletion
strain and yeast GFP clone collectionscan be placed under the control of the weakerMET3 (Von Pawel-
Rammingen et al., 2000) and CUP1 (Arnoldo et al., 2008) promo-
tors. In these cases, expression is controlled by the presence of
methionine or copper in the media, respectively. Another option
is the tightly controlled tetracycline-responsive tetO promotor
(Belli et al., 1998; Skrzypek et al., 2003). This is not an endoge-
nous yeast promotor, and modified yeast strains that encode
a tetR repressor must be used to tightly control expression.
The copy number of the genes encoding the effector proteins
will also influence protein levels in yeast. It is easiest to either
encode the effector protein on centromere-containing (copy
number 1–3) or 2 micron (copy number 40–60) plasmids, al-
though targeted homologous recombination can be used to
introduce a single copy of a gene into the yeast genome. Studies
with Shigella effector proteins suggest that the sensitivity and
specificity of growth inhibition as an indicator of effector proteins
is optimized when the proteins are expressed from low copy-
number plasmids (Slagowski et al., 2008). However, it is possible
that effector proteins from other pathogens will not be as well
expressed in yeast, and in these cases it might prove fruitful
to express the effector proteins from high copy-number
plasmids.
Another variable to consider when expressing effector pro-
teins in yeast is the addition of an epitope tag. Evidence exists
that fusion of effector proteins to GFP can influence growth inhi-
bition due to their expression (Slagowski et al., 2008). In the
majority of cases, fusion to GFP results in increased growth inhi-
bition, presumably due to increased expression and/or stability
of the effector proteins (March et al., 2003). However, there are
also examples of where fusion to GFP decreased toxicity of the
effector proteins, presumably due to steric interference. If the
location of the secretion signal of the effector protein is known,
fusing to GFP to this domain is presumably less likely to interferewith the activity of the effector protein, since this domain is
thought to be unstructured.
There are numerous options available for monitoring yeast
growth inhibition due to expression of an effector protein. One
relatively simple assay for detecting qualitative differences in
growth is to plate serial dilutions of saturated yeast cultures on
inducing media (Lesser and Miller, 2001; Sisko et al., 2006).
Quantitative measurements of growth inhibition can be achieved
by measuring the optical density of liquid cultures in conven-
tional growth assays or in 96-well liquid growth assays (Slagow-
ski et al., 2008). Similarly, growth can be monitored using dyes
that monitor cellular respiration (Sisko et al., 2006). In addition,
growth on solid media can be quantified (Dudley et al., 2005).
Growth is usually measured under standard laboratory condi-
tions. However, effector proteins targeting cellular processes
that are not normally rate-limiting for growth will not be detected
under these conditions. To address this, ‘‘stressors’’ can be in-
troduced into the growth media at doses that do not perturb
growth of wild-type yeast (Sisko et al., 2006; Slagowski et al.,
2008). For example, expression of Shigella OspB only inhibits
growth when caffeine is added to the media (Slagowski et al.,
2008). In addition to identifying additional candidate effector pro-
teins, conditional sensitivity to a particular stressor can provide
clues as to the cellular pathway targeted by the effector protein.
For example, sensitivity to high salt can be due to targeting of
a variety of cellular processes including mitogen-activated
protein kinase (MAPK) signaling pathways, while sensitivity to
nocodazole suggests a perturbation in microtubules.
There are several potential situations that might limit yeast as
a model system to study specific effector proteins. For example,
since the effector proteins are normally delivered as preformed
toxinsdirectly intohostcells,proteins that requirebacteria-specific
modificationsmight not function in yeast. Similarly, the topology ofCell Host & Microbe 4, July 17, 2008 ª2008 Elsevier Inc. 9
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might not bemaintained in yeast. Tocircumvent this latter issue, an
option is toexpresssolubledomainsof effectorproteins.Thisstrat-
egy proved fruitful in studying the Chlamydia trachomatis Inc pro-
teins, a subset of Chlamydia effector proteins that are membrane
associated (Sisko et al., 2006).
Significance of Growth Inhibition as a Reporter
for Effector Proteins
There is growing evidence to suggest that yeast growth inhibition
is a sensitive and specific reporter of effector proteins. A survey
of the behavior of effector proteins and bacterial-confined pro-
teins encoded on the Shigella virulence plasmid revealed that
almost half of twenty effector proteins inhibit yeast growth
when expressed from a low copy-number plasmid. A molecular
mechanism was already known for seven of these proteins, five
of which target conserved cellular processes. Notably,
expression of only these five effectors inhibited yeast growth.
Expression of the other two, which interact with proteins not
found in yeast, did not affect yeast growth. Expression of only
1 of 20 bacterial-confined proteins, a bacterial toxin, severely in-
hibited growth. Notably, coexpression of the bacterial antitoxin
suppressed yeast toxicity (Slagowski et al., 2008). Other bacte-
rial toxin-antitoxin systems have also been observed to behave
similarly in yeast (Picardeau et al., 2003; Kristoffersen et al.,
2000). Presumably, these toxins target cellular processes
conserved among prokaryotes and yeast.
Since some bacterial housekeeping proteins are involved in
cellular processes conserved from yeast to prokaryotes, their
expression also can interfere with yeast growth. For example,
expression of Legionella sterol desaturase, a homolog of
S. cerevisiae ERG25, an essential protein involved in ergosterol
biosynthesis, presumably inhibits yeast growth by perturbing
membrane synthesis (Campodonico et al., 2005). However, sev-
eral high-throughput studies suggest that yeast growth inhibition
due to the expression of bacterial housekeeping proteins is
rare. For example, only 2 of 371 essential Pseudomonas aerugi-
nosa proteins severely inhibit yeast growth (Arnoldo et al., 2008).
Similarly, a screen that covered 60% of the Legionella pneu-
mophilia genome identified only six bacterial-confined proteins
that inhibit yeast growth (Campodonico et al., 2005). And, lastly,
expression of only 3 of 1100 Francisella tularenesis proteins,
two-thirds of the Francisella proteome, reproducibly but mini-
mally, inhibit growth (Slagowski et al., 2008). In the case of the
Pseudomonas and Legionella screens the proteins were
expressed from a high copy-number plasmid while the Franci-
sella proteins were expressed from a low copy-number plasmid.
Thus, growth inhibition due to expression of bacterial-confined
proteins appears to be rare, and when it does occur it appears
that it is often to due to conserved targeting of cellular processes
and not a nonspecific effect due to overexpression of a heterolo-
gous protein in yeast.
Subcellular Localization Patterns of Effector Proteins
in Yeast Can Yield Clues to Effector Protein Function
Accumulating evidence suggests that subcellular localization
patterns of effector proteins expressed de novo in yeast accu-
rately reflect their localization when injected into host cells
during the course of an infection. This includes localization to10 Cell Host & Microbe 4, July 17, 2008 ª2008 Elsevier Inc.the plasma membrane, nucleus, and the actin cytoskeleton (Be-
nabdillah et al., 2004; Lesser and Miller, 2001; Sisko et al., 2006;
Skrzypek et al., 2003). This targeting presumably reflects con-
served interactions with eukaryotic structures and/or proteins.
However, we have observed that bacterial proteins that normally
never contact host cells often localize to specific yeast cellular
compartments, including the nucleus and endoplasmic reticu-
lum, presumably due to fortuitous sequences encoded within
the bacteria proteins (data not shown). Thus, localization to spe-
cific yeast subcellular compartments is not as sensitive or spe-
cific an indicator of effector proteins as growth inhibition.
The simplest way to determine the localization of an effector
protein in yeast is to fuse the protein to a fluorescent tag such
as GFP. Alternatively, one can conduct indirect immunofluores-
cence studies on fixed cells. To determine whether an effector
protein localizes to specific yeast subcellular compartments,
cells expressing the protein can be stained with DNA-binding
dyes like DAPI (nucleus), fluorescently labeled rhodamine (actin),
Mitotracker (mitochondria), or antibody markers for particular
compartments. In addition, yeast reporter strains that constitu-
tively express a series of mRFP fusion proteins that localize to
specific structures are available and can be used in colocaliza-
tion studies (Table 2) (Huh et al., 2003).
Localization patterns of bacterial effector proteins in yeast can
provide valuable insights regarding the molecular mechanism of
the proteins. For example, when expressed in yeast, Salmonella
SipA (SspA) colocalizes with the actin cytoskeleton, where it dis-
rupts the normal yeast actin cytoskeletal polarity and prevents
turnover of actin cables (Lesser and Miller, 2001). This was the
first demonstration of an in vivo interaction of SipA and actin.
Subsequent work in mammalian systems demonstrated that
SipA bundles actin filaments by tethering actin subunits in
opposing strands (Galkin et al., 2002). These activities reflect
the role of SipA in promoting the formation of membrane ruffles
that mediate the uptake of Salmonella into host cells.
Novel insights into pathogenesis strategies can also be
gleaned from localization patterns. For example, when Sisko
and colleagues screened a library of Chlamydia trachomatis
ORFs fused to GFP in yeast, they observed that four putative
C. trachomatis effector proteins colocalized with RFP-Erg6,
a protein that localizes to yeast lipid droplets (Sisko et al.,
2006). The investigators subsequently demonstrated that
Table 2. mRFP Reporter Strains for Colocalization Studies
Strain Localization
mRFP-Sac6 actin
mRFP-Cop1 early Golgi
mRFP-Snf7 endosome
mRFP-Sec13 ER to Golgi vesicle
mRFP-Anp1 Golgi apparatus
mRFP-Chc1 late Golgi/clathrin
mRFP-Erg6 lipid particle
mRFP-Sik1 nucleolus
mRFP-Nic96 nuclear periphery
mRFP-Pex3 peroxisome
mRFP-Spc42 spindle pole
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of Chlamydia containing vacuoles and that this activity is impor-
tant for the survival and replication of Chlamydia within the host
cells (Kumar et al., 2006).
Expression of Effector Proteins CanMediate Alterations
in Morphology of Yeast Cytoskeleton and Organelles
The previous sections of this review describe unbiased ap-
proaches to identify and characterize effector proteins. Another
approach is to screen for effector proteins that target specific
eukaryotic cellular processes. For example, many pathogens
manipulate the host actin cytoskeleton during the course of in-
fection. Intracellular pathogens like Shigella and Salmonella de-
liver effector proteins that promote the formation of membrane
ruffles that mediate their uptake into normally nonphagocytic
cells (Cossart and Sansonetti, 2004; Ly and Casanova, 2007).
Enteropathogenic E. coli delivers proteins into host cells that
result in the formation of membrane pedestals that allow them
to adhere to host cells (Hayward et al., 2006). In contrast, Yersi-
nia species deliver effector proteins into host cells that disrupt
the actin cytoskeleton and prevent their uptake bymacrophages
(Viboud and Bliska, 2005).
Rho GTPases are highly conserved molecular switches that
regulate the dynamics of the actin cytoskeleton of both yeast
and mammals (Etienne-Manneville and Hall, 2002). These
proteins are activated by GEFs (GTP exchange factors) and
inactivated by GAPs (GTPase-activating proteins). Effector pro-
teins that mimic GAPs, GEFs, and activated GTPases have all
been identified (Figure 1; Table 3). Although the specific re-
sponses to these proteins differ when introduced into in yeast
and mammalian cells, they have been observed to exhibit anal-
Figure 1. Bacterial Effector Proteins Target Conserved Eukaryotic
Signaling Pathways
The intersection of a MAPK signaling pathway and Rho-GTPase cycling is il-
lustrated along with the effector proteins from bacteria that target these path-
ways. Effector proteins with functions that mimic a mammalian protein are
displayed in blue, while those that modify and deactivate mammalian proteins
are displayed in red.ogous molecular activities when expressed in the different cell
types.
Expression of Yersinia YopE, a RhoGAP, inhibits the formation
of actin stress fibers in mammalian cells and inhibits polarity of
the yeast actin cytoskeleton (Lesser and Miller, 2001; Von
Pawel-Rammingen et al., 2000). In contrast, expression of Sal-
monella SopE2, a Rho GEF that activates Cdc42, results in the
formation of membrane ruffles in mammalian cells and causes
yeast to filament, a phenotype associated with activation of the
filamentous growth pathway, a MAPK pathway regulated by
Cdc42 (Rodriguez-Pachon et al., 2002). Expression of E. coli
Map, a functional mimic of activated Cdc42, results in the forma-
tion of filopodia in mammalian cells and results in the formation
of large unbudded yeast cells with a depolarized yeast actin
cytoskeleton (Rodriguez-Escudero et al., 2005). Unexpectedly,
this phenotype resembles that of yeast expressing a dominant-
negative, rather than a constitutively active, Cdc42 allele. One
possible explanation for these results is that Mapmay be binding
Cdc42-interacting proteins such that the endogenous yeast
Cdc42 is unable to recruit proteins required to promote
polarization.
Expression of E. coli EspG disrupts polarity of the yeast actin
cytoskeleton (Rodriguez-Escudero et al., 2005) as well as in-
hibits the formation of microtubules (Hardwidge et al., 2005).
Expression of both EspG and its Shigella homolog, VirA, se-
verely inhibits yeast growth (Rodriguez-Escudero et al., 2005;
Slagowski et al., 2008). In addition, both proteins bind mamma-
lian tubulin and destabilize microtubules in in vitro assays
(Hardwidge et al., 2005; Yoshida et al., 2002). Thus, effector
proteins that target microtubules are also amenable to analyses
in yeast.
Morphology of yeast organelles, such as the vacuole, can also
provide clues to effector protein function. Sato and colleagues
observed that expression of Pseudomonas aeruginosa ExoU
was not only severely toxic to yeast but also resulted in a vacuole
fragmentation phenotype. Based on this observation the investi-
gators hypothesized that expression of ExoU either blocked vac-
uole biogenesis or disrupted vacuolar membranes. They went on
to demonstrate that ExoU is a phospholipase whose activity is
responsible for ExoU toxicity in both yeast and mammalian cells
(Sato et al., 2003).
Table 3. Summary of Effector Proteins that Target Rho GTPases
and MAPKs
Effector Protein Molecular Activity (Yeast References)
Yersinia YopE Rho GAP (Lesser and Miller, 2001;
Von Pawel-Rammingen et al., 2000)
Shigella IpgB2 Rho mimic (Alto et al., 2006)
Salmonella SptP Rho GAP (Rodriguez-Pachon et al., 2002)
Salmonella SopE2 Rho GEF (Rodriguez-Pachon et al., 2002)
E. coli Map Cdc42 mimic (Alto et al., 2006)
Yersinia YopJ MAPKK acetyltransferase (Yoon et al., 2003)
Vibrio VopA MAPKK acetyltransferase (Trosky et al., 2007)
Shigella OspF MAPK phosphothreonine lyase
(Kramer et al., 2007)
Shigella IpaH9.8 MAPKK (STE7) ubiquitin E3 ligase
(Rohde et al., 2007)Cell Host & Microbe 4, July 17, 2008 ª2008 Elsevier Inc. 11
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MAPK-Signaling Cascades
MAPK-signaling cascades are ubiquitous eukaryotic cellular pro-
cesses that are often targeted by effector proteins. In mammals,
as in yeast, these signaling pathways regulate a variety of cellular
activities. Numerous pathogens have been demonstrated to tar-
get this pathway in order to regulate the host innate immune
response (Shanet al., 2007). Although theoutputs of thesesignal-
ing cascadesdiffer fromyeast tomammals, the signaling compo-
nents of these pathways are highly conserved. These pathways
are characterized by a phosphorelay of three kinases that act to
transduce and amplify a variety of signals in both yeast andmam-
mals (Figure 1). Thesepathways canbeactivated throughdiverse
receptors and signaling molecules, including the Rho GTPases
described above.
Yeast encode four well-characterized MAPK signaling path-
ways: the mating pathway, the filamentous growth pathway,
the cell wall integrity (CWI) pathway, and the hyperosmotic
growth/glycerol (HOG) pathway (Chen and Thorner, 2007). The
basal activity of each of these MAPK signaling cascades is
very low when yeast is grown under standard laboratory condi-
tions. Experimental conditions exist to activate each pathway,
i.e., exposure to mating factor induces the mating and filamen-
tous growth pathways, osmotic stressors (high salt) induce the
HOG pathway, and heat stress or hypo-osmotic shock induces
the CWI integrity pathway. By measuring the activity of the
MAPK signaling pathways in the presence and absence of the
inducers, it is possible to screen for effector proteins that either
activate or inhibit the pathways.
The activity of the MAPK pathways can be monitored in a vari-
ety of assays. First, transcriptional reporters for activation of all
four pathways are available (Jung et al., 2002; Madhani and
Fink, 1997; Tatebayashi et al., 2006; Trueheart et al., 1987). Sec-
ond, mammalian phosphospecific p42/44 MAPK antibodies de-
tect activated yeast MAPKs in the CWI, mating, and filamentous
growth pathways while phospho p38 antibodies recognize the
terminal MAPK in the HOG pathway. Third, one can monitor
the activity of specific MAPK pathways by screening for pheno-
types associated with their activation or inactivation. For exam-
ple, inhibition of the mating pathway results in a complete or
partial sterile phenotype, which can be detected by quantitative
mating assays or by monitoring resistance to alpha factor
(Hoffman et al., 2002; Sprague, 1991).
As summarized in Table 3 and outlined in Figure 1, many of the
bacterial effector proteins target MAPK signaling pathways. All
but one of these effector proteins exhibits the same activity in
both yeast and mammalian cells. The one exception is
IpaH9.8, an E3 ubiquitin ligase that targets the mating pathway
MAPKK (STE7), but not its mammalian homologs, for degrada-
tion (Rohde et al., 2007). Nevertheless, the yeast studies were
instrumental in determining a function for a large family of effec-
tor proteins that was previously unknown.
Analyses conducted to identify the yeast cellular target of
IpaH9.8 demonstrated how the specific step in a pathway tar-
geted by an effector protein can be identified using a variety of
readily available tools (Rohde et al., 2007). Rohde and colleagues
initially determined that IpaH9.8 targets the mating cascade
when they observed that yeast expressing IpaH9.8 were insensi-
tive to mating factor, a condition that normally arrests growth of12 Cell Host & Microbe 4, July 17, 2008 ª2008 Elsevier Inc.haploid yeast. They next demonstrated that IpaH9.8 prevented
the activation of a mating pathway transcriptional reporter
when the mating pathway was activated by either mating factor
or a constitutively active MAPKKK allele. In this way, they were
able to determine that IpaH9.8 acts downstreamof theMAPKKK.
Next, using commercially available antibodies, they demon-
strated that IpaH9.8-expressing yeast had greatly diminished
levels of STE7 (MAPKK) but normal levels of Fus3 (MAPK).
Thus, using widely available tools they were able to determine
that IpaH9.8 acts at the level of the MAPKK.
The investigators did not identify the mammalian target of
IpaH9.8 despite screening for alterations in the levels of at least
two MAPKKs in cells infected with Shigella. Nevertheless, they
were able to demonstrate that another member of this well-con-
served family of effector proteins, a Salmonella homolog, does
target a mammalian protein for degradation. Thus, while the
studies in yeast did not clearly identify the host cell target for
IpaH9.8, these studies were instrumental in determining the
molecular mechanism of this family of effector proteins. Until
the actual host cell target of IpaH9.8 is identified, the significance
of the ubiqutination of STE7 will remain unclear as IpaH9.8 may
target a mammalian protein that shares homology with STE7, in-
cluding those mammalian MAPKKs not previously investigated
by the investigators.
Yeast as a System to Identify Proteins
that Perturb Vesicle Trafficking
Other conserved cellular pathways commonly targeted by effec-
tor proteins include those involved in vesicle trafficking. While
some intracellular pathogens escape from endocytic vacuoles
and survive freely in the cytoplasm, others survive within mem-
brane-bound compartments that they modify to promote their
own survival as well as to avoid fusion with lysosomes. At least
two Legionella pneumophila proteins, RalF and LidA, play
a role in modifying the Legionella-containing vacuole and inhibit
growth when expressed in yeast (Campodonico et al., 2005;
Derre and Isberg, 2005). Both of these proteins target eukaryotic
proteins conserved from yeast to mammals. Expression of LidA
interferes with the processing of carboxypeptidase Y (CPY),
a protein that is modified as it is processed from the ER to the
Golgi to the vacuole. Thus, LidA likely inhibits yeast growth by
interfering with vesicular trafficking (Derre and Isberg, 2005).
An elegant yeast screen previously used to identify yeast
strains impaired in the transport of proteins to the vacuole was
adapted to screen for Legionella pneumophila effector proteins
that specifically target this trafficking pathway. As described
above, CPY is a vacuolar protein that is normally transported
from the ER-Golgi vacuole. The fusion of the terminal 50 amino
acids of CPY to invertase (Inv), a protein that breaks down
sucrose, is sufficient to target Inv to the yeast vacuole, where it
is degraded. However, when the vacuole transport pathway is
disrupted, the fusion protein is missorted to yeast cell surface,
where it is secreted. The secreted invertase is functional, and
its activity can be detected in a simple overlay assay. A genomic
library of L. pneumophila chromosomal DNA fragments under
the control of the constitutive yeast ADH1 promotor was
introduced into the CPY-Inv reporter strain and screened for
those proteins that perturb vesicle trafficking. Three previously
unknown Legionella effector proteins were subsequently
Cell Host & Microbe
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in this screen, presumably due to their toxicity to yeast. This
screen should be applicable to screening ORFs from a variety
of bacterial pathogens.
Yeast Functional Genomic Screens Provide Unique
Insights into the Host Cell Processes Targeted
by Effector Proteins
The previous sections of this review all describe relatively
straightforward strategies for identifying the cellular targets in
yeast of the effector proteins. Since these targets are often
conserved, studies in yeast can provide valuable insights re-
garding the roles of these proteins in pathogenesis. Functional
genomics provides a powerful alternative approach. Given its
relatively small genome, genetic tractability and well-developed
functional genomic tools, S. cerevisiae is an ideal model organ-
ism for multidisciplinary systems-biology studies. Since over
75% of the yeast genome is functionally annotated, systematic
identification of genes or proteins that modulate a phenotype
can identify pathways and processes involved in that pheno-
type, which, in turn, can provide insights into the phenotype’s
etiology.
Yeast functional genomic screens have recently been used to
characterize the functions of two Shigella effector proteins,
IpgB2 and OspF. In both cases, the effector protein under the
control of the inducible GAL1/10 promotor was introduced into
the complete set of 4800 yeast haploid deletion strains, each
deleted for a nonessential annotated yeast ORF. The two studies
demonstrate different approaches that can be undertaken to
identify host cell processes targeted by effector proteins. For
IpgB2, Alto and colleagues screened for and identified three de-
letion strains that suppress the lethal yeast phenotype associ-
ated with expression of this protein (Alto et al., 2006). In the
case of OspF, Kramer and colleagues systematically screened
for and identified 78 yeast deletion strains hypersensitive to ex-
pression of OspF (Kramer et al., 2007). While the suppressor
screens specifically identified deletion strains that counteracted
the effects of expression of IpgB2, the hypersensitivity screens
identified deletion strains that exacerbated the OspF growth
phenotype.
Remarkably, both functional genomic screens suggested that
IpgB2 and OspF were targeting the yeast cell wall integrity path-
way, a highly conservedMAPK signaling pathway. IpgB2 toxicity
was alleviated when proteins essential for the integrity of this
signal pathway were deleted. In contrast, many of the deletion
strains hypersensitive to expression of OspF were observed to
be involved in processes that required the presence of an intact
cell wall. In parallel with the genome-wide phenotypic screens,
both laboratories used microarray technology to identify ge-
nome-wide alterations in the expression of yeast mRNAs due
to expression of the effector proteins. In both cases, expression
patterns of genes normally regulated by the CWI pathway were
disrupted. In the case of IpgB2 the pathway was constitutively
activated, while in the case of OspF the pathway was repressed.
These functional genomic studies, in part, resulted in the classi-
fication of IpgB2 as a founding member of a new family of effec-
tor proteins that mimic activated Rho GTPases and OspF as
a member of a newly established class of MAPK phosphatases,
phosphothreonine lyases.Although both the screens described above were conducted
with the yeast deletion strain collection, similar approaches
can be undertaken by systematically examining the effects of
expressing effector proteins in one of the available collections
of yeast strains that conditionally overexpress each of the anno-
tated yeast ORFs (Gelperin et al., 2005; Sopko et al., 2006).
Suppression of Yeast Growth Inhibition Provides a Novel
Assay for Detection of Small Molecule Inhibitors
As described earlier, expression of effector proteins can result in
severe yeast growth inhibition. If these effector proteins play
a major role in virulence, then one can potentially identify new
antivirulence molecules by screening for compounds that inhibit
the effector protein activity. This strategy was recently under-
taken to screen a library of 56,000 small molecules for those
that inhibit yeast growth inhibition due to expression of Pseudo-
monas aeruginosa ExoS (Arnoldo et al., 2008). Six compounds
were identified, one of which, exosin, also protects mammalian
cells from the toxic effects of ExoS, an effector protein that
exhibits both RhoGAP and ADP-ribosyltransferase activity
(ADPRT). Interestingly, exosin specifically targets the ExoS
ADPRT activity, which appears to be sufficient to both
suppress ExoS yeast toxicity as well as to prevent the induction
of apoptosis of host cells due to infection of P. aeruginosa. One
could also use this approach to screen for compounds that
inhibit the activity of essential bacterial proteins whose expres-
sion severely inhibits yeast growth.
There are several advantages of conducting screens for small
molecule inhibitors in yeast. First, since the screens are con-
ducted outside of the context of an infection, they are conducted
under Biosafety Level 1 conditions. Second, since small mole-
cules are being screened for alleviation of growth inhibition and
the readout is restoration of growth, toxic compounds that target
conserved eukaryotic cellular pathways will likely be screened
out. Lastly, since compounds that restore yeast growth are pre-
sumably able to penetrate both the yeast cell wall and plasma
membrane, small molecule screens conducted in yeast should
enrich for compounds that can be taken up by mammalian cells.
Of note, yeast strains that no longer express proteins involved in
mediating pleiotrophic drug resistance (Pdr1, Pdr3, and Snq2) as
well as proteins involved in synthesis of the plasma membrane
(Erg6) can be used to potentially increase the intracellular
concentrations of the small molecules being screened.
Conclusions
This review describes many approaches using S. cerevisiae that
numerous laboratories studying plant and human pathogens are
undertaking to both identify and characterize bacterial proteins
involved in virulence. Notably, even though this relatively simple
eukaryote does not encode an immune system, effector proteins
involved in modulating the host immune response like Yersinia
YopJ and Shigella OspF are amenable to analyses in yeast be-
cause they target highly conserved MAPK signaling pathways.
The yeast system should prove fruitful in identifying effector
proteins that play roles in modulating other processes unique
to multicellular organisms that are also regulated by conserved
signaling pathways.
The verdict is still out on the general utility of the yeast system
for studying bacterial effector proteins. It has been clearlyCell Host & Microbe 4, July 17, 2008 ª2008 Elsevier Inc. 13
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and MAPK signaling cascades in both yeast and mammals, and,
as reviewed above, targeted assays can now be used to screen
for such proteins. Although this review focused on common
functional themes shared among virulence factors, effector pro-
teins have been observed to target a variety of cellular processes
conserved from yeast to mammals (for review, see Valdivia,
2004). For example,P. aeruginosa ExoS is an ADPRT that targets
members of Ras family in both yeast and mammalian cells,
Salmonella SipA (SspA) colocalizes and decreases the turnover
of actin filaments in both yeast andmammalian cells, and numer-
ous plant effector proteins inhibit programmed cell death of both
yeast and plant cells (Abramovitch et al., 2006; Jamir et al.,
2004). Thus, it seems likely that the yeast model system will
prove useful in identifying additional functions for a variety of
effector proteins, especially when unbiased genetic approaches
are undertaken.
The main advantage of studying bacterial pathogens in yeast
as opposed to other model systems like Caenorhabditis elegans
or Drosophila melanogaster is the relative simplicity of this
system. The simplicity may also be an Achilles heel, though, as
some effector proteins undoubtedly target host proteins unique
to mammals. Indeed, some effector proteins known to target
nonconserved eukaryotic proteins do not visibly affect growth
when expressed in yeast. Furthermore, although bacterial effec-
tor proteins are known to work in concert, all studies so far have
focused on individual effector proteins outside of the context of
an infection. Yet, coexpression of multiple effector proteins in
yeast is quite feasible and should be a fruitful undertaking in
the future. The relative ease of working with S. cerevisiae and
the wealth of available experimental tools coupled with the
high conservation of many eukaryotic cellular processes make
this system a very powerful one in which to study mechanisms
of bacterial pathogenesis.
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